Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Transplant, Liver
and you are
between 18 and 75
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

To study spironolactone to prevent CNI kidney injury.

Provided treatments

  • Drug: Spironolactone
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02883400. The sponsor of the trial is Atrium Health and it is looking for 36 volunteers for the current phase.
Official trial title:
Spironolactone to Prevent or Delay CNI Toxicity in Liver Transplant Recipients